Carboxy therapeutic effectiveness in comparison with fractional Q-Switched ND:YAG laser for the treatment of periorbital dark circles
Phase 1
- Conditions
- Eye dark circles.
- Registration Number
- IRCT20080901001159N24
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
The cause of darkness, structural and reducing fat in this area is not
Age between 18 and 65 years old
Exclusion Criteria
Active infection in the face
Pregnancy and breastfeeding
History of cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preorbital hyperpigmentation. Timepoint: Session 0, 4 and 6 during treatment and 3 months after treatment. Method of measurement: Intensity of the darkening of the skin around the eyes compared to other areas of the face with Mexameter device.;Satisfaction amount. Timepoint: After completion of treatment. Method of measurement: Comparison of reduction preorbital hyper pigmentation by patient , before and after treatment According to schedule ( score 0 to 10 ).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive carboxy therapy's efficacy in periorbital hyperpigmentation compared to fractional Q-Switched ND:YAG laser?
How does carboxy therapy compare to fractional Q-Switched ND:YAG laser in phase I trials for periorbital dark circles in terms of clinical outcomes?
Which biomarkers correlate with treatment response to carboxy therapy or fractional Q-Switched ND:YAG laser in periorbital hyperpigmentation patients?
What are the safety profiles and adverse event management strategies for carboxy therapy versus fractional Q-Switched ND:YAG laser in cosmetic dermatology?
What combination therapies or alternative laser types synergize with carboxy therapy for periorbital dark circles as explored in IRCT20080901001159N24?